Literature DB >> 6352105

Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent.

O Crivelli, C Lavarini, E Chiaberge, A Amoroso, P Farci, F Negro, M Rizzetto.   

Abstract

A cytoplasmic autoantibody is described which gives a distinct immunofluorescence pattern in tissues of man and of varied animal species. Fluorescence is maximal in human substrates; it is strong in human hepatocytes and nephron cells and weak in thyroid adrenal and pancreatic cells. Complement fixation and fluorescence absorption studies have shown that the homologous antigen is localized in the microsomal membranes of human liver. The autoantibody was found in 13% of 81 carriers of HBsAg with chronic delta infection. It was not detected in patients with acute delta infection or in HBsAg positive and HBsAg negative patients without delta infection. The apparently exclusive occurrence of this antibody in chronic delta infection suggests that its expression is induced by persistence of the viral event.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352105      PMCID: PMC1536193     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  ANTIBODY TO RIBOSOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  B C STURGILL; R R CARPENTER
Journal:  Arthritis Rheum       Date:  1965-04

2.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

3.  Interrelations of hepatitis B antigen and autoantibodies in chronic idiopathic liver disease.

Authors:  N D Finlayson; K Krohn; K E Anderson; P T Jokelainen; A M Prince
Journal:  Gastroenterology       Date:  1972-10       Impact factor: 22.682

4.  Microsomal antibodies in active chronic hepatitis and other disorders.

Authors:  M Rizzetto; G Swana; D Doniach
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

5.  Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses.

Authors:  J C Homberg; M Rizzetto; D Doniach
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

6.  Smooth muscle antibody in malignant disease.

Authors:  J M Whitehouse; E J Holborow
Journal:  Br Med J       Date:  1971-11-27

7.  Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.

Authors:  M Rizzetto; J W Shih; D J Gocke; R H Purcell; G Verme; J L Gerin
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

8.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

9.  Australia antigen and autoantibodies in chronic hepatitis.

Authors:  T L Vischer
Journal:  Br Med J       Date:  1970-06-20

10.  Hepatic disorders associated with liver-kidney microsomal antibodies.

Authors:  M G Smith; R Williams; G Walker; M Rizzetto; D Doniach
Journal:  Br Med J       Date:  1974-04-13
View more
  20 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Autoimmunity in liver diseases.

Authors:  C P Strassburg; P Obermayer-Straub; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 3.  Nature of autoantigens and autoantibodies in autoimmune hepatitis.

Authors:  M P Manns; K H Meyer zum Büschenfelde
Journal:  Springer Semin Immunopathol       Date:  1990

4.  Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.

Authors:  R Klein; U M Zanger; T Berg; U Hopf; P A Berg
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

5.  Autoimmunity in chronic liver disease caused by hepatitis delta virus.

Authors:  D Zauli; C Crespi; F B Bianchi; A Craxi; E Pisi
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

6.  Detection of anti-mitochondrial antibodies by ELISA and Western-blot techniques and identification by one and two-dimensional gel electrophoresis of M2 target antigens.

Authors:  G Dighiero; C Magnac; J de Saint Martin; N Abuaf
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

7.  Chronic active hepatitis associated with liver-kidney microsomal antibody of an autoimmune type. Two familial cases.

Authors:  C Buffet; J C Homberg; G Pelletier; K Turner; J P Etienne
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

8.  Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases.

Authors:  M Manns; K H Meyer zum Büschenfelde; J Slusarczyk; H P Dienes
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

Authors:  U M Zanger; H P Hauri; J Loeper; J C Homberg; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.

Authors:  R Seelig; M Renz; G Bünger; H Schröter; H P Seelig
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.